BUPIVACAINE LIPOSOME Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Bupivacaine Liposome, and what generic alternatives are available?
Bupivacaine Liposome is a drug marketed by Hengrui Pharma and is included in one NDA.
The generic ingredient in BUPIVACAINE LIPOSOME is bupivacaine. There are twelve drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the bupivacaine profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for BUPIVACAINE LIPOSOME?
- What are the global sales for BUPIVACAINE LIPOSOME?
- What is Average Wholesale Price for BUPIVACAINE LIPOSOME?
Summary for BUPIVACAINE LIPOSOME
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 1 |
| Clinical Trials: | 49 |
| Patent Applications: | 4,386 |
| DailyMed Link: | BUPIVACAINE LIPOSOME at DailyMed |
Recent Clinical Trials for BUPIVACAINE LIPOSOME
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Yongtao Sun | Phase 4 |
| Rutgers, The State University of New Jersey | Phase 2/Phase 3 |
| Zhejiang Cancer Hospital | Phase 4 |
Pharmacology for BUPIVACAINE LIPOSOME
| Drug Class | Amide Local Anesthetic |
| Physiological Effect | Local Anesthesia |
US Patents and Regulatory Information for BUPIVACAINE LIPOSOME
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hengrui Pharma | BUPIVACAINE LIPOSOME | bupivacaine | INJECTABLE, LIPOSOMAL;INJECTION | 214348-001 | Jul 1, 2024 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Hengrui Pharma | BUPIVACAINE LIPOSOME | bupivacaine | INJECTABLE, LIPOSOMAL;INJECTION | 214348-002 | Jul 1, 2024 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
